arrow
A

Aurelio Maggio

foundation franco and piera cutino
H指数:49
被引数:7,605

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration

为地中海贫血护理的未来做准备:利用可扩展疗法、人工智能和全球合作

2026-10-060
PRE
Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases

绒毛取样术在罕见单基因病产前诊断中的应用:876例病例的开发、验证及临床结局

2026-05-230
PRE
Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia

量化最优输血患者中红细胞输注量所致的发病风险

2025-10-030
OAAI
Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study

β-地中海贫血中贫血和铁控制对预后的影响:纵向de-LIGHT研究的数据

2025-07-310
PRE
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients
2023-03-152
OA
Reply to Hepatocellular carcinoma in thalassemia and other hemoglobinopathies
CANCER
IF5.1
2023-03-140
OAAI
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021
CANCER
IF5.1
2022-11-0212
OAAI
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
2022-01-0328
OA
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection
2021-12-1010
OA
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia
2021-12-1024
OA
The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies
2021-08-3024
OAAI